GCMG
ABBV icon

Gyroscope Capital Management Group’s AbbVie ABBV Stock Holding History

Gyroscope Capital Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.93K Hold
19,000
– – ﹤0.01% 218
2023
Q2 		$20.1K Buy
+19,000
New +$2.79M ﹤0.01% 187
2019
Q3 		– Sell
-19,400
Closed -$5K – 121
2019
Q2 		$5K Hold
19,400
– – ﹤0.01% 118
2019
Q1 		$12K Buy
+19,400
New +$1.59M ﹤0.01% 119

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gyroscope Capital Management Group's ABBV Position: Q3 2023 in Review

Gyroscope Capital Management Group increased its AbbVie (ABBV) stake by 8.8% in Q3 2023, buying an estimated $415K and bringing the position to 34,989 shares worth $5.22M. The position accounts for 1.2% of the portfolio, ranked #28.

Gyroscope Capital Management Group first reported a position in ABBV in Q1 2015 and has held it in 33 quarters since. The position peaked at $6.51M in Q4 2017. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Gyroscope Capital Management Group held 34,989 shares of AbbVie worth $5.22M as of Q3 2023.
  • Gyroscope Capital Management Group bought 2,825 AbbVie shares in Q3 2023, an estimated $415K.
  • AbbVie made up 1.2% of Gyroscope Capital Management Group's portfolio in Q3 2023, its #28 holding.
  • Gyroscope Capital Management Group first reported a position in AbbVie in Q1 2015 and has held it in 33 quarters since.
  • Gyroscope Capital Management Group's AbbVie position peaked at $6.51M in Q4 2017.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Gyroscope Capital Management Group's 13F filing for Q3 2023, filed 13 Nov 2023.